Skip to main content

icosapent ethyl

Generic: ICOSAPENT ETHYL·Brand: ICOSAPENT ETHYL, VASCEPA

icosapent ethyl: sourced relationships with 1 company.

icosapent ethyl evidence translation

What we can confirm

No verified FDA or trial count is available.

What it means

Source-backed records connect icosapent ethyl to AMRN; that link alone does not prove the drug works.

What to watch

Evidence is limited; missing information remains unknown.
BioSniper AIPage evidence connected

Prepared research question

How could icosapent ethyl → AMRN affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 0 study sponsors

Related indications

MARINE indication: adjunct to diet to reduce triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia; REDUCE-IT indication: adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients with elevated triglyceride levels (≥150 mg/dL) and either established cardiovascular disease or diabetes mellitus and two or more additional risk factors for cardiovascular disease.Reducing triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia; reducing persistent cardiovascular risk in select high-risk patients as an adjunct to maximally tolerated statin therapy.Reduction of triglyceride levels in adult patients with severe hypertriglyceridemia; reduction of persistent cardiovascular risk in select high-risk patients

Study sponsors

No additional listed-company sponsor is linked.

Dated Pipeline Records (3)
CompanyDated record stage
AMARIN CORP PLCUK (AMRN)
owner · Reported 2025-03-12 · Current development: unknownSource
MARINE indication: adjunct to diet to reduce triglyceride le…
Approved
AMARIN CORP PLCUK (AMRN)
developer · Reported 2026-03-02 · Current development: unknownSource
Reducing triglyceride levels in adult patients with severe (…
Approved
AMARIN CORP PLCUK (AMRN)
developer · Reported 2026-03-02 · Current development: unknownSource
Reduction of triglyceride levels in adult patients with seve…
Approved